Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

The identification of new therapeutic strategies is urgently needed for the management of patients affected by anaplastic thyroid cancer (ATC) due to their short survival and poor prognosis. Aim of the study was to determine the activity of the combination irinotecan/sunitinib on ATC cell growth in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Lett
Main Authors: Di Desidero, Teresa, Antonelli, Alessandro, Orlandi, Paola, Ferrari, Silvia Martina, Fioravanti, Anna, Alì, Greta, Fontanini, Gabriella, Basolo, Fulvio, Francia, Giulio, Bocci, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8022336/
https://ncbi.nlm.nih.gov/pubmed/28964784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.09.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados